Table 1. Characteristics of Survivors Diagnosed With an Invasive First Primary Cancer in 1992-2011 at Ages 20 to 84 Years and ≥5-Year Survival in 12 SEER Registries.
| Survivorsa | Person-years of follow-up 5 y after first primary cancer | ||
|---|---|---|---|
| No. (%) | Total | Mean | |
| Total | 1 537 101 (100.0) | 11 197 890 | 7.3 |
| Sex | |||
| Men | 786 384 (51.2) | 5 499 426 | 7.0 |
| Women | 750 717 (48.8) | 5 698 464 | 7.6 |
| Age at first primary cancer diagnosis, yb | |||
| 20-39 | 130 296 (8.5) | 1 242 585 | 9.5 |
| 40-49 | 205 737 (13.4) | 1 831 888 | 8.9 |
| 50-64 | 569 091 (37.0) | 4 502 560 | 7.9 |
| 65-84 | 631 977 (41.1) | 3 620 857 | 5.7 |
| Calendar year of first primary cancer diagnosis | |||
| 1992-1999 | 541 867 (35.3) | 5 712 727 | 10.5 |
| 2000-2005 | 471 463 (30.7) | 3 641 246 | 7.7 |
| 2006-2011 | 523 771 (34.1) | 1 843 917 | 3.5 |
| Months of follow-up since first primary cancer | |||
| 60-119 | 1 537 101 (100.0) | 6 137 717 | 4.0 |
| 120-179 | 903 187 (58.8) | 3 255 469 | 3.6 |
| ≥180 | 437 985 (28.5) | 1 804 704 | 4.1 |
| Racec | |||
| White | 1 252 830 (81.5) | 9 224 122 | 7.4 |
| Black | 137 530 (8.9) | 941 916 | 6.8 |
| Asian or Pacific Islander | 124 839 (8.1) | 880 854 | 7.1 |
| American Indian/Alaska Native | 6955 (0.5) | 47 937 | 6.9 |
| Not recorded in SEER registryd | 14 947 (1.0) | 103 061 | 6.9 |
| SEER registry recoded for first primary cancer | |||
| Los Angeles | 311 264 (20.3) | 2 262 141 | 7.3 |
| Seattle (Puget Sound) | 183 429 (11.9) | 1 343 692 | 7.3 |
| Detroit (metropolitan) | 182 366 (11.9) | 1 324 790 | 7.3 |
| San Francisco-Oakland (metropolitan) | 169 744 (11.0) | 1 253 329 | 7.4 |
| Connecticut | 169 628 (11.0) | 1 241 774 | 7.3 |
| Iowa | 133 776 (8.7) | 960 833 | 7.2 |
| Atlanta (metropolitan) | 103 403 (6.7) | 763 923 | 7.4 |
| San Jose-Monterey | 86 822 (5.6) | 645 027 | 7.4 |
| Utah | 73 620 (4.8) | 525 616 | 7.1 |
| New Mexico | 67 306 (4.4) | 474 743 | 7.1 |
| Hawaii | 50 788 (3.3) | 368 945 | 7.3 |
| Rural Georgia | 4955 (0.3) | 33 077 | 6.7 |
| SEER historic stage | |||
| Localized | 673 540 (43.8) | 5 228 418 | 7.8 |
| Localized/regional (prostate cases) | 322 192 (21) | 2 154 564 | 6.7 |
| Regional | 263 132 (17.1) | 1 857 475 | 7.1 |
| Distant | 86 356 (5.6) | 480 412 | 5.6 |
| Unstaged | 131 468 (8.6) | 945 715 | 7.2 |
| Blanke | 60 413 (3.9) | 531 305 | 8.8 |
| Reasons for exit from the current study | |||
| End of study | 925 463 (60.2) | ||
| Death | 550 485 (35.8) | ||
| Lost to follow-up | 61 153 (4.0) | ||
Abbreviation: SEER, Surveillance, Epidemiology, and End Results Program.
a
Survivor follow-up was until Dec 31, 2017. The current version of the SEER database did not allow determination of variation (standard deviation) for survivor age and person-years of follow-up.
b
Mean age was 60.4 years.
c
Race in the SEER registries was based on information abstracted from medical records or death certificates (eMethods in Supplement 1).
d
Not included in the mortality analysis.
e
Indicates cases with certain site-year combinations that were not covered by SEER Historic Stage A (see the SEER Variable and Recode Definitions on the SEER Historic Stage A).22